Year: 2021

**Not for distribution to United States Newswire Services or release publication, distribution or dissemination, directly or indirectly, in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws** CALGARY, Alberta and TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC) (“Magnetic North” or the “Company”) is pleased to announce its intention to conduct a non-brokered private placement (the “Financing”) of Series A Preferred Shares for gross proceeds of up to $2,000,006.50 CAD. The aggregate proceeds of the Financing may be increased at the discretion of the Company due to market demand. Proceeds of the Financing are intended for investment by the Company in certain opportunities and for general corporate purposes. First closing is expected...

PRESS RELEASE AB SCIENCE RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) AUTHORIZATION TO RESUME PATIENT ENROLMENT IN THE PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) STUDY AB19001 HAS NOW BEEN AUTHORIZED IN 15 COUNTRIES IN EUROPE, USA, AND OTHER REGIONS AND IS ACTIVELY ENROLLING PATIENTS Paris, 18 November 2021, 8.30pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that it has received authorization from the United States Food and Drug Administration (FDA) to resume patient enrollment in the confirmatory Phase 3 study of masitinib (AB19001) in patients with amyotrophic lateral sclerosis (ALS). Study AB19001 has been authorized in 15 countries in Europe, USA, and other regions and is actively enrolling patients. Dr Christian Fassotte, Chief Medical Officer of AB Science said: “We are...

OMAHA, Neb., Nov. 18, 2021 (GLOBE NEWSWIRE) — Werner Enterprises (Nasdaq: WERN), a premier transportation and logistics provider, has earned multiple Military Friendly® designations for 2022. Werner was honored to receive the Military Friendly® Employers Gold Award and be recognized as a Top 10 Military Spouse Friendly® Employer and Military Friendly® Brand. “There is a level of pride that goes along with being a military service member,” said Chairman, President and Chief Executive Officer Derek Leathers. “At Werner, we take pride in our veterans and active military for their outstanding service to our country and the sacrifices they have made for our freedoms, and we are honored to support them during the second chapter of their careers.” Werner was awarded the designations for its efforts in creating sustainable and meaningful...

CALGARY, Alberta, Nov. 18, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.WS, SUGR.DB) (“Sugarbud” or the “Company“) announces that the Company has submitted an application to the TSX Venture Exchange (“TSXV“) to approve the extension of the expiry date of 18,500,000 outstanding common share purchase warrants of the Company issued on November 18, 2019 (the “2019 Private Placement Warrants”), and 16,272,075 outstanding common share purchase warrants of the Company issued on December 20, 2019 (the “2019 Rights Offering Warrants”, and collectively with the 2019 Private Placement Warrants, the “Warrants”). The 2019 Private Placement Warrants and the 2019 Rights Offering Warrants were set to expire on November 18, 2021 and December 20, 2021, respectively. Under the...

Strategic partnership designed to mitigate near-term supply chain challenges and stimulate market-share capture of more than $100 billion in global government-sponsored broadband infrastructure initiatives PLANO, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) — DZS (NASDAQ: DZSI), a global leader in broadband connectivity platforms and communications software solutions, today announced a strategic sourcing partnership with Advanced Media Technologies, Inc. (AMT), a leading CATV and broadband electronic equipment value-added reseller. This relationship paves the way for communications service providers, MSOs and enterprise customers spanning North America, Caribbean and Latin America to proactively manage supply chain and ensure reliable and predictable sourcing across the full line of DZS leading-edge broadband connectivity solutions. “Unprecedented...

KATY, TX, Nov. 18, 2021 (GLOBE NEWSWIRE) — Tonner-One World Holdings, Inc “the Company” (OTC: TONR TWTR: @TonnerOne), an aggressive FinTech development company, is pleased to present the CEO Introduction Letter to Shareholders. *** Dear Shareholders, As a shareholder of Tonner-One World Holdings, Inc., you are receiving this letter to inform you of a recent decision by your company’s Board of Directors to transform its business model to precisely focus on acquisitions and operation of businesses and assets in the fast-growth Fintec growth industry. We’re presently, actively reviewing merger and acquisition candidates, operating cryptocurrency exchange, Defi or Fintec businesses, to join us in our journey into the rapidly expanding Crypto Fintech industry. This decision – to pursue acquisitions and operation of businesses and assets...

LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that Mr. Paul Maier has been appointed as a non-executive independent director of the board of directors of the Company (the “Board”). He will hold office as an independent director until the next annual meeting of shareholders, or until his successor has been elected or appointed. Mr. Maier has also been appointed as a member of the Audit Committee and Corporate Governance and Nominating Committee and Chair of the Compensation Committee. Mr. Maier joins Small Pharma with over 30 years’ experience in senior executive roles across the biopharmaceutical and biotech industry. He has a successful track record at U.S. publicly listed...

YARDLEY, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the closing of the previously announced underwritten public offering of 28,750,000 shares of its common stock at a public offering price of $1.60 per share, including the exercise in full by the underwriters of their option to purchase up to 3,750,000 additional shares of common stock. The gross proceeds of the offering to Optinose are $46.0 million, before deducting underwriting discounts and before offering expenses. Optinose intends to use the net proceeds of the offering for working capital and general corporate purposes, including the commercialization of XHANCE, the clinical development of XHANCE for a follow-on indication for the...